Table 3. Subgroup Analysis of TYE combined with urokinase thrombolysis.
Sub group | TYE | TYE combined with urokinase thrombolysis | ||||||
---|---|---|---|---|---|---|---|---|
No. of patients | Age (years) | Male (%) | Duration (d) | No. of patients | Age (years) | Male (%) | Duration (d) | |
0-1 line | 25 | 52 | 48 | 10 | 15 | 48 | 53 | 5 |
>2 lines | 9 | 48 | 67 | 6 | 19 | 52 | 42 | 10 |
>4 lines | 5 | 50 | 60 | 12 | 9 | 56 | 77 | 9 |
>6 lines | 3 | 56 | 67 | 9 | 6 | 46 | 67 | 7 |
Abbreviation: TYE, transluminal Nd:YAG laser embolysis.